Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 192 entries
Sorted by: Best Match Show Resources per page
Calcification response of a key phytoplankton family to millennial-scale environmental change.

Scientific reports

McClelland HL, Barbarin N, Beaufort L, Hermoso M, Ferretti P, Greaves M, Rickaby RE.
PMID: 27677230
Sci Rep. 2016 Sep 28;6:34263. doi: 10.1038/srep34263.

Coccolithophores are single-celled photosynthesizing marine algae, responsible for half of the calcification in the surface ocean, and exert a strong influence on the distribution of carbon among global reservoirs, and thus Earth's climate. Calcification in the surface ocean decreases...

Origin of an insect outbreak: escape in space or time from natural enemies?.

Oecologia

Maron JL, Harrison S, Greaves M.
PMID: 28547245
Oecologia. 2001 Feb;126(4):595-602. doi: 10.1007/s004420000558. Epub 2001 Feb 01.

Initiation of insect outbreaks is poorly understood, and may involve sporadic events that temporarily release insect populations from predation or parasitism. While studying a declining outbreak of the western tussock moth (Orgyia vetusta) on bush lupine (Lupinus arboreus), we...

Erratum: Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.

Oncotarget

Trerotola M, Ganguly KK, Fazli L, Fedele C, Lu H, Dutta A, Liu Q, De Angelis T, Riddell LW, Riobo NA, Gleave ME, Zoubeidi A, Pestell RG, Altieri DC, Languino LR.
PMID: 26513314
Oncotarget. 2015 Oct 20;6(32):34038. doi: 10.18632/oncotarget.6187.

No abstract available.

Immunohistochemical Analysis of Radical Prostatectomy Specimens After 8 Months of Neoadjuvant Hormonal Therapy.

Molecular urology

Paterson RF, Gleave ME, Jones EC, Zubovits JT, Goldenberg SL, Sullivan LD.
PMID: 10851334
Mol Urol. 1999;3(3):277-286.

Neoadjuvant hormone therapy (NHT) prior to radical prostatectomy (RP) results in residual foci of atrophic glands, which can be difficult to identify with hematoxylin-eosin staining, raising the possibility that the low positive-margin rates are an artifact of pathologic understaging....

Clinical Experience with Intermittent Androgen Suppression in Prostate Cancer: Minimum of 3 Years' Follow-Up.

Molecular urology

Goldenberg SL, Gleave ME, Taylor D, Bruchovsky N.
PMID: 10851335
Mol Urol. 1999;3(3):287-292.

This report reviews the long-term follow-up of a prospective Phase II evaluation of intermittent androgen suppression in the treatment of prostate cancer. A total of 87 patients have been entered in this protocol. At the time of this report,...

Urinary bladder endocervicosis: a case report and review of the literature.

The Canadian journal of urology

Jones EC, Gleave ME, Andreou C.
PMID: 12741980
Can J Urol. 1996 Mar;3(1):206-210.

Endocervicosis, a mucinous analogue of endometriosis, is a rare, non-neoplastic mullerian lesion that may involve the urinary bladder. This lesion has only recently been described in the pathologic literature and, to the best of our knowledge, it has not...

Venovenous bypass in renal cell carcinoma with caval tumor thrombus.

The Canadian journal of urology

Ko DS, Scudamore CH, Gleave ME, Sullivan LD, Hemming A, Goldenberg SL.
PMID: 12803715
Can J Urol. 1995 Jul;2(3):164-71.

We describe two patients with a T3bN2M0 renal cell carcinoma with caval extension to the hepatic veins in which we successfully utilized extracorporeal femoralaxillary venovenous bypass for tumor thrombus resection. The inherent advantage of this modified venovenous bypass are...

Advanced prostate cancer: an update.

Reviews in urology

Ziada A, Crawford ED, Schröeder FH, Gleave ME, Miller PD, Garnick MB.
PMID: 16986039
Rev Urol. 2000;2:S35-9.

A number of therapeutic options are available or on the horizon for patients for whom initial treatment of localized prostate cancer has failed. Currently under study are time of therapy, maximum androgen blockade, and palliative and adjunctive therapies.

Multiple Rodent Ulcers.

Proceedings of the Royal Society of Medicine

Glen EM.
PMID: 19993001
Proc R Soc Med. 1945 Jan;38(3):127-8.

No abstract available.

Befriending your competitors.

Nature materials

Cleave V.
PMID: 18167493
Nat Mater. 2008 Jan;7(1):3-5. doi: 10.1038/nmat2093.

No abstract available.

Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.

Oncotarget

Sahoo D, Wei W, Auman H, Hurtado-Coll A, Carroll PR, Fazli L, Gleave ME, Lin DW, Nelson PS, Simko J, Thompson IM, Leach RJ, Troyer DA, True LD, McKenney JK, Feng Z, Brooks JD.
PMID: 29464091
Oncotarget. 2018 Jan 05;9(5):6550-6561. doi: 10.18632/oncotarget.23973. eCollection 2018 Jan 19.

The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and...

Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia.

Nature communications

Vijayakrishnan J, Studd J, Broderick P, Kinnersley B, Holroyd A, Law PJ, Kumar R, Allan JM, Harrison CJ, Moorman AV, Vora A, Roman E, Rachakonda S, Kinsey SE, Sheridan E, Thompson PD, Irving JA, Koehler R, Hoffmann P, Nöthen MM, Heilmann-Heimbach S, Jöckel KH, Easton DF, Pharaoh PDP, Dunning AM, Peto J, Canzian F, Swerdlow A, Eeles RA, Kote-Jarai Z, Muir K, Pashayan N, Greaves M, Zimmerman M, Bartram CR, Schrappe M, Stanulla M, Hemminki K, Houlston RS.
PMID: 30664635
Nat Commun. 2019 Jan 21;10(1):419. doi: 10.1038/s41467-018-08106-9.

The original version of this Article contained an error in the spelling of a member of the PRACTICAL Consortium, Manuela Gago-Dominguez, which was incorrectly given as Manuela Gago Dominguez. This has now been corrected in both the PDF and...

Showing 1 to 12 of 192 entries